Expression significance of biomarker MORC4 in colorectal cancer patients and its relationship with pathological features and prognosis

Table 1 Clinical and pathological data of colorectal cancer patients

Pathological characteristics	Cases	Proportion (%)
Gender	-	-
Male	81	56.64
Female	62	43.36
Age (years)	-	-
< 60	19	13.29
≥ 60	124	86.71
Tumor location	-	-
Left side	112	78.32
Right side	31	21.68
Tumor diameter (cm)	-	-
≤ 5	94	65.73
> 5	49	34.27
Degree of differentiation	-	-
Low differentiation	21	14.69
Moderate + high differentiation	122	85.31
T stage	-	-
T1 + T2 stage	13	9.09
T3 + T4 stage	130	90.91
N stage	-	-
N0 stage	88	61.54
Nx stage	55	38.46
M stage	-	-
M0 stage	127	88.81
M1 stage	16	11.19
TNM stage	-	-
I + II	85	59.44
III + IV	58	40.56
Serum CEA (μg/L)	-	-
< 5	67	46.85
≥ 5	76	53.15

TNM: Tumor-node-metastasis; CEA: Carcinoembryonic antigen.